VA
OCUL icon

VR Adviser’s Ocular Therapeutix OCUL Stock Holding History

VR Adviser’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.6M Buy
10,346,926
+3,031,379
+41% +$28.9M 3.27% 8
2025
Q4 		$88.8M Sell
7,315,547
-5,845,915
-44% -$71M 4.39% 6
2025
Q3 		$154M Buy
13,161,462
+399,000
+3% +$4.77M 8.66% 3
2025
Q2 		$118M Hold
12,762,462
– – 8.88% 2
2025
Q1 		$93.5M Hold
12,762,462
– – 7.96% 3
2024
Q4 		$109M Hold
12,762,462
– – 7.48% 2
2024
Q3 		$111M Hold
12,762,462
– – 5.82% 2
2024
Q2 		$87.3M Hold
12,762,462
– – 5.56% 4
2024
Q1 		$116M Buy
12,762,462
+4,986,702
+64% +$35.4M 5.52% 3
2023
Q4 		$34.7M Buy
+7,775,760
New +$23M 2.38% 11

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return